John, Peter
Pulanco, Marc C.
Galbo, Phillip M. Jr.
Wei, Yao
Ohaegbulam, Kim C.
Zheng, Deyou http://orcid.org/0000-0003-4354-5337
Zang, Xingxing http://orcid.org/0000-0001-5380-1942
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (3R01CA175495-09S1)
U.S. Department of Defense (BC190403)
Article History
Received: 28 December 2021
Accepted: 19 April 2022
First Online: 6 May 2022
Competing interests
: X.Z. is an inventor on patent 9447186 covering cancer immunotherapy targeting B7x. P.J., M.C.P., Y.W., and X.Z. are inventors on a pending patent (Novel anti-B7x antibodies and derivative products). Other authors declare no conflicts of interest